CARULLI, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.744
AS - Asia 6.526
EU - Europa 5.614
SA - Sud America 863
AF - Africa 140
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.564
SG - Singapore 2.291
CN - Cina 1.676
GB - Regno Unito 1.565
IT - Italia 925
HK - Hong Kong 836
BR - Brasile 655
DE - Germania 631
VN - Vietnam 619
SE - Svezia 493
FI - Finlandia 388
PL - Polonia 368
UA - Ucraina 338
FR - Francia 257
TR - Turchia 248
RU - Federazione Russa 245
KR - Corea 141
IN - India 133
BG - Bulgaria 114
BD - Bangladesh 87
CA - Canada 77
ID - Indonesia 76
IQ - Iraq 73
AR - Argentina 69
MX - Messico 54
JP - Giappone 53
PK - Pakistan 42
NL - Olanda 39
AE - Emirati Arabi Uniti 38
IE - Irlanda 38
BE - Belgio 32
ES - Italia 32
ZA - Sudafrica 31
MA - Marocco 29
AT - Austria 28
EC - Ecuador 28
VE - Venezuela 27
TW - Taiwan 26
CO - Colombia 23
PH - Filippine 22
CL - Cile 21
MY - Malesia 21
SA - Arabia Saudita 21
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
KE - Kenya 17
IR - Iran 16
AU - Australia 15
CH - Svizzera 14
CR - Costa Rica 14
PY - Paraguay 14
DZ - Algeria 12
EG - Egitto 12
ET - Etiopia 12
JO - Giordania 12
LT - Lituania 11
NO - Norvegia 10
PE - Perù 10
RO - Romania 10
AZ - Azerbaigian 9
BO - Bolivia 9
NP - Nepal 9
OM - Oman 9
TT - Trinidad e Tobago 9
PA - Panama 8
AL - Albania 7
BY - Bielorussia 6
DK - Danimarca 6
KG - Kirghizistan 6
SI - Slovenia 6
TH - Thailandia 6
TN - Tunisia 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
EU - Europa 5
GE - Georgia 5
HU - Ungheria 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
RS - Serbia 5
DO - Repubblica Dominicana 4
IL - Israele 4
JM - Giamaica 4
NI - Nicaragua 4
PS - Palestinian Territory 4
UG - Uganda 4
AM - Armenia 3
GR - Grecia 3
HR - Croazia 3
KZ - Kazakistan 3
MD - Moldavia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BF - Burkina Faso 2
BH - Bahrain 2
GH - Ghana 2
KH - Cambogia 2
KW - Kuwait 2
Totale 27.884
Salva come PNG Salva come JPEG
Città #
Singapore 1.583
Fairfield 1.379
Santa Clara 1.249
Ashburn 1.213
Southend 978
Hong Kong 826
Woodbridge 759
Houston 731
Chandler 697
Jacksonville 551
Chicago 531
San Jose 487
Seattle 470
Wilmington 468
Cambridge 463
Dearborn 416
Ann Arbor 408
Los Angeles 369
Hefei 355
Warsaw 354
Beijing 340
Nyköping 319
London 284
Helsinki 266
Modena 229
Salt Lake City 210
Ho Chi Minh City 189
The Dalles 167
San Diego 155
Hanoi 153
New York 140
Izmir 134
Munich 130
Seoul 129
Council Bluffs 123
Princeton 121
Tampa 114
Sofia 111
Eugene 101
Shanghai 94
Elk Grove Village 90
Lauterbourg 88
Buffalo 67
Dallas 65
São Paulo 59
Fremont 54
Sterling 54
Milan 52
Moscow 52
Des Moines 48
Lancaster 48
Columbus 47
Jakarta 46
Guangzhou 40
Baghdad 39
Bologna 38
Frankfurt am Main 38
Redwood City 38
Rome 35
Orem 34
Boardman 33
Turku 33
Phoenix 32
Tokyo 32
Dublin 31
Brussels 28
Detroit 28
Dulles 27
Brooklyn 26
Falls Church 26
Bremen 25
Miami 25
Haiphong 24
Mexico City 24
Da Nang 23
Kunming 23
Chennai 22
San Mateo 22
Toronto 22
Parma 20
Dongguan 19
Manchester 19
Montreal 19
San Francisco 19
Zhengzhou 18
Amsterdam 17
Dhaka 17
Hounslow 17
Norwalk 17
Nuremberg 17
Tashkent 17
Bari 16
Kansas City 15
Mumbai 15
Rio de Janeiro 15
Atlanta 14
Boston 14
Kilburn 14
Nanjing 14
Stockholm 14
Totale 19.681
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 696
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 465
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 445
Gender, fatty liver and GGT 414
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 408
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 408
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 405
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 403
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 394
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 390
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 390
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 375
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 373
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 372
Review article: diabetes, genetics and ethnicity 366
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 363
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 355
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 352
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 351
Hepatic steatosis and insulin resistance: Does etiology make a difference? 343
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 341
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 341
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 335
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 334
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 333
Endocrine and liver interaction: the role of endocrine pathways in NASH 331
Telomere length elongation after weight loss intervention in obese adults 325
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 319
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 314
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 313
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 308
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 303
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 302
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 300
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 297
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 294
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 293
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 288
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 282
Olanzapine metabolic side effects: a weight gain issue? 280
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 276
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 272
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 268
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 266
Telomere and telomerase in chronic liver disease and hepatocarcinoma 261
The Individual Care Plan (ICP): proposal of a model to improve the communication between hospital and primary health care services 261
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 260
Review article: effect of bile salt pool composition on hepatic and biliary functions 256
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 252
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 249
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 243
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 240
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. 236
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 233
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 230
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 226
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 223
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 222
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 222
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 220
Telomere shortening as genetic risk factor of liver cirrhosis 220
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 214
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 212
Regolazione della sintesi di colesterolo e acidi biliari 211
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 205
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 204
Increase degradation of cholesterol via the alternate pathway of bile acid biosynthesis in primary hypercholesterolemia. 202
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 202
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 201
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 201
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 200
Telomeres and atherosclerosis 199
Cirrosi criptogenetiche. Un report di 5 pazienti 198
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption 197
Gender differences in chronic alcoholic and viral liver diseases 196
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 191
Fatty liver, carotid disease and gallstones: A study ofage-related associations 190
Reply 189
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 188
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 187
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 185
The genetic basis of Insulin resistance. A brief review 184
Cholestatic icterus: is there still a role for the clinic? 183
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 180
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 177
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 172
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 168
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 166
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 165
Risk for cardiovascular events in a local population of diabetic patients 164
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 160
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 160
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome. 156
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 152
La calcolosi biliare. 150
Does fatty liver associate with carotid atherosclerosis? 150
regulation of bile acid synthesis in humans: availability of newly sythetized cholesterol is a limiting fator during pharmacological inhibition of bile acid recirculation. 150
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 149
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 144
non alcoholic fatty liver disease ( NAFLD) :is femlae sex safer? 143
Totale 26.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.916
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021572 0 0 0 0 0 0 0 0 0 290 183 99
2021/20222.398 108 303 160 203 64 115 182 147 282 133 421 280
2022/20231.970 220 203 170 197 211 312 42 173 248 15 78 101
2023/20241.332 55 71 86 91 253 134 209 165 26 31 65 146
2024/20254.606 120 56 87 322 944 705 304 236 431 213 489 699
2025/20269.427 470 305 606 1.317 2.613 1.022 1.086 404 837 767 0 0
Totale 28.102